3 not yet recruiting. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Not yet recruiting 3 |
Follow Yayi He: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Lomustine Combined With Anlotinib as Interventional Therapy for Extensive-stage Small Cell Lung Cancer Resistant to Second-line and Above Treatment Lomustine, Anlotinib - SCLC, Extensive Stage | Phase 2 | Not yet recruiting | Yayi He | 46 | 2026-06-01 | 2026-06-08 |
| A Study of Benmelstobart, Anlotinib, Chemotherapy and Thoracic Radiotherapy for People With Extensive-stage Small Cell Lung Cancer benmelstobart, Anlotinib, Carboplatin or cisplatin - SCLC, Extensive Stage | Phase 2 | Not yet recruiting | Yayi He | 33 | 2026-04-20 | 2026-04-20 |
| Benmelstobart Plus Anlotinib, Chemotherapy and Thoracic Radiation for Limited-Stage Small Cell Lung Cancer Benmelstobart, Anlotinib, Cisplatin or carboplatin - Limited-stage Small Cell Lung Cancer (LS-SCLC) | Phase 2 | Not yet recruiting | Yayi He | 27 | 2026-04-20 | 2026-04-20 |
anlotinib (3) · Carboplatin (2) · Cisplatin (2) · Etoposide (2) · Lomustine (1)